Technical Analysis for NRSNW - NeuroSense Therapeutics Ltd. - warrant

Grade Last Price % Change Price Change
D 0.17 41.20% 0.05
NRSNW closed up 41.2 percent on Wednesday, November 20, 2024, on 60 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Stochastic Reached Oversold Weakness 0.00%
Wide Bands Range Expansion 0.00%
Gapped Up Strength 0.00%
Oversold Stochastic Weakness 0.00%
MACD Bearish Signal Line Cross Bearish 41.20%
Narrow Range Bar Range Contraction 41.20%
Wide Bands Range Expansion 41.20%
Fell Below 20 DMA Bearish 41.20%
Fell Below 200 DMA Bearish 41.20%
Fell Below 50 DMA Bearish 41.20%

   Recent Intraday Alerts

Alert Time
Rose Above Previous Day's High about 18 hours ago
Up 5% about 18 hours ago
Up 3% about 18 hours ago
Up 2% about 18 hours ago
Up 1% about 18 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases in the United States and internationally. Its lead product is PrimeC, an extended-release oral formulation of a fixed dose combination of ciprofloxacin and celecoxib for the treatment of amyotrophic lateral sclerosis. The company's preclinical pipeline includes StabiliC for the treatment of Parkinson's disease; and CogniC for the treatment of Alzheimer's disease. NeuroSense Therapeutics Ltd. was incorporated in 2017 and is headquartered in Herzliya, Israel.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Alzheimer's Disease Parkinson's Disease Neurodegenerative Diseases Amyotrophic Lateral Sclerosis Treatment Of Parkinson's Disease Senescence Treatment Of Alzheimer's Disease Neurodegenerative Disease Clinical Neuroscience

Is NRSNW a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 0.55
52 Week Low 0.073
Average Volume 4,437
200-Day Moving Average 0.20
50-Day Moving Average 0.17
20-Day Moving Average 0.17
10-Day Moving Average 0.19
Average True Range 0.05
RSI (14) 49.49
ADX 21.25
+DI 23.65
-DI 24.64
Chandelier Exit (Long, 3 ATRs) 0.14
Chandelier Exit (Short, 3 ATRs) 0.26
Upper Bollinger Bands 0.25
Lower Bollinger Band 0.09
Percent B (%b) 0.49
BandWidth 94.10
MACD Line 0.00
MACD Signal Line 0.00
MACD Histogram -0.0019
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.22
Resistance 3 (R3) 0.21 0.19 0.21
Resistance 2 (R2) 0.19 0.18 0.19 0.20
Resistance 1 (R1) 0.18 0.17 0.19 0.19 0.20
Pivot Point 0.16 0.16 0.16 0.16 0.16
Support 1 (S1) 0.15 0.15 0.16 0.16 0.14
Support 2 (S2) 0.13 0.14 0.13 0.14
Support 3 (S3) 0.12 0.13 0.13
Support 4 (S4) 0.13